Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,554 across all filing types
Latest filing 2021-01-12 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 100% confidence The document is a formal letter addressed to stock exchanges regarding the issuance of duplicate share certificates due to lost or misplaced original certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015, which pertains to share certificate management. The content is a notification about share certificate replacement, not a financial report, earnings release, or management discussion. It does not contain financial data, audit information, or meeting materials. This type of announcement fits best under Regulatory Filings (RNS), as it is a compliance-related disclosure that does not fit other specific categories.
2021-01-12 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has issued duplicate share certificates ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the issuance of duplicate share certificates due to lost or misplaced original certificates. It references compliance with SEBI Listing Obligations and Disclosure Requirements, Regulation 39(3). The content is a notification about share certificate replacement, not a financial report, meeting materials, or management discussion. It is a regulatory announcement related to share certificates but does not fit into categories like Share Issue/Capital Change or Transaction in Own Shares since it concerns duplicate certificates, not new issuance or buybacks. Given the nature and length of the document, it is best classified as a Regulatory Filing (RNS), which is the fallback for miscellaneous compliance and disclosure documents that do not fit other categories.
2021-01-12 English
Updates
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, provided by the Registrar and Share Transfer Agent for the quarter ended 31st December 2020. It is a short letter addressed to stock exchanges requesting to take the certificate on record. There is no substantive financial data or detailed report content. The document is primarily an attestation/certification letter rather than a full report or announcement of financial results. According to the Certification Rule and the Menu vs Meal Rule, such a document should be classified as a Regulatory Filing (RNS) rather than an Interim Report or any other report type.
2021-01-07 English
Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company has provided the enclosed certificate for the quarter ended 31st December 2020 under Regulation ....
Regulatory Filings Classification · 95% confidence The document is a certificate provided by the Registrar and Share Transfer Agent (RTA) under Regulation 74(5) of the Securities and Exchange Board of India (SEBI) (Depositories and Participants) Regulations, 2018 for the quarter ended 31st December 2020. It confirms the processing of dematerialisation requests and compliance with SEBI circulars. The document is a formal attestation or certification letter rather than a financial report or announcement of financial results. It does not contain financial statements or substantive financial data. The document length is short (2746 characters) and it is primarily a certification letter submitted to stock exchanges. Therefore, it fits the criteria for Regulatory Filings (RNS) as it is a regulatory compliance certificate and not a full report or announcement of financial results or corporate actions.
2021-01-07 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates, referencing SEBI regulations. It is a notification about a specific event related to share certificates, not a financial report, management change, or earnings release. The content is brief and focused on regulatory compliance for share certificate loss. This fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2020-12-24 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates, citing SEBI regulations. It contains details about the lost certificates and requests the information to be taken on record. The document is short (1168 characters) and is an announcement related to share certificates, not a financial report or detailed filing. It does not contain financial data, management discussion, or regulatory certifications. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2020-12-24 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.